The harvested tumors from PBISe treated murine HCC demonstrated decrease in the angiogenesis markers like Vegf-A, Vegf-R3 and CD34 along with the proliferation marker PCNA compared to the control (Figure 5C). This evidence concerns the gene VEGFA and hepatocellular carcinoma.